Noscapine HCl
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 329459

CAS#: 912-60-7 (HCl)

Description: Noscapine, also known as Narcotine, Nectodon, Nospen, Anarcotine and (archaic) Opiane, is a benzylisoquinoline alkaloid from plants of the poppy family, without painkilling properties. This agent is primarily used for its antitussive (cough-suppressing) effects. Noscapine's antitussive effects appear to be primarily mediated by its σ–receptor agonist activity. Evidence for this mechanism is suggested by experimental evidence in rats. Pretreatment with rimcazole, a σ-specific antagonist, causes a dose-dependent reduction in antitussive activity of noscapine. Noscapine, and its synthetic derivatives called noscapinoids, are known to interact with microtubules and inhibit cancer cell proliferation. Noscapine HCl was discontinued.

Chemical Structure

img
Noscapine HCl
CAS# 912-60-7 (HCl)
Product data Instruction

Theoretical Analysis

MedKoo Cat#: 329459
Name: Noscapine HCl
CAS#: 912-60-7 (HCl)
Chemical Formula: C22H24ClNO7
Exact Mass: 0.00
Molecular Weight: 449.884
Elemental Analysis: C, 58.74; H, 5.38; Cl, 7.88; N, 3.11; O, 24.89

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Noscapine Hydrochloride; Narcotine, Nectodon, Nospen, Anarcotine and (archaic) Opiane.

IUPAC/Chemical Name: (S)-6,7-dimethoxy-3-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one hydrochloride

InChi Key: MFLVZFXCSKVCSH-URBRKQAFSA-N

InChi Code: InChI=1S/C22H23NO7.ClH/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18;/h5-6,9,17-18H,7-8,10H2,1-4H3;1H/t17-,18+;/m1./s1

SMILES Code: O=C1O[C@H]([C@@H]2N(C)CCC3=CC4=C(OCO4)C(OC)=C23)C5=C1C(OC)=C(OC)C=C5.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info: Related CAS# 128-62-1 (Noscapine free base) 912-60-7 (Noscapine hydrochloride)

Product Data:
Product Data
Instruction:
View handling instruction
Biological target: An alkaloid with anticancer and antitussive activities.
In vitro activity: Noscapine suppressed both inducible and constitutive NF-kappaB activation in tumor cells through inhibition of IkappaB kinase, leading to inhibition of phosphorylation and degradation of IkappaBalpha. Noscapine also suppressed phosphorylation and nuclear translocation of p65, leading to inhibition of NF-kappaB reporter activity induced by various components of the NF-kappaB activation pathway. Reference: Cancer Res. 2010 Apr 15;70(8):3259-68. https://pubmed.ncbi.nlm.nih.gov/20354190/
In vivo activity: In a syngeneic murine model of established s.c. melanoma, noscapine treatment resulted in an 85% inhibition of tumor volume on day 17 when delivered by gavage compared with untreated animals (P

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMF 30.0 66.68
DMSO 30.0 66.68
DMSO:PBS (pH 7.2) (1:1) 0.5 1.11
Ethanol 1.0 2.22

Preparing Stock Solutions

The following data is based on the product molecular weight 449.88 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Akhter S, Irfan HM, Alamgeer, Ullah A, Jahan S, Roman M, Latif MB, Mustafa Z, Almutairi FM, Althobaiti YS. Noscapine hydrochloride (benzyl-isoquinoline alkaloid) effectively prevents protein denaturation through reduction of IL-6, NF-kB, COX-2, Prostaglandin-E2 in rheumatic rats. Saudi Pharm J. 2022 Dec;30(12):1791-1801. doi: 10.1016/j.jsps.2022.10.008. Epub 2022 Oct 19. PMID: 36601515; PMCID: PMC9805980. 2. Sung B, Ahn KS, Aggarwal BB. Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway. Cancer Res. 2010 Apr 15;70(8):3259-68. doi: 10.1158/0008-5472.CAN-09-4230. Epub 2010 Mar 30. PMID: 20354190; PMCID: PMC2855771. 3. Landen JW, Lang R, McMahon SJ, Rusan NM, Yvon AM, Adams AW, Sorcinelli MD, Campbell R, Bonaccorsi P, Ansel JC, Archer DR, Wadsworth P, Armstrong CA, Joshi HC. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res. 2002 Jul 15;62(14):4109-14. PMID: 12124349. 4. Mahmoudian M, Mojaverian N. Efffect of noscapine, the antitussive opioid alkaloid, on bradykinin-induced smooth muscle contraction in the isolated ileum of the guinea-pig. Acta Physiol Hung. 2001;88(3-4):231-7. doi: 10.1556/APhysiol.88.2001.3-4.5. PMID: 12162581.
In vitro protocol: 1. Akhter S, Irfan HM, Alamgeer, Ullah A, Jahan S, Roman M, Latif MB, Mustafa Z, Almutairi FM, Althobaiti YS. Noscapine hydrochloride (benzyl-isoquinoline alkaloid) effectively prevents protein denaturation through reduction of IL-6, NF-kB, COX-2, Prostaglandin-E2 in rheumatic rats. Saudi Pharm J. 2022 Dec;30(12):1791-1801. doi: 10.1016/j.jsps.2022.10.008. Epub 2022 Oct 19. PMID: 36601515; PMCID: PMC9805980. 2. Sung B, Ahn KS, Aggarwal BB. Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway. Cancer Res. 2010 Apr 15;70(8):3259-68. doi: 10.1158/0008-5472.CAN-09-4230. Epub 2010 Mar 30. PMID: 20354190; PMCID: PMC2855771.
In vivo protocol: 1. Landen JW, Lang R, McMahon SJ, Rusan NM, Yvon AM, Adams AW, Sorcinelli MD, Campbell R, Bonaccorsi P, Ansel JC, Archer DR, Wadsworth P, Armstrong CA, Joshi HC. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res. 2002 Jul 15;62(14):4109-14. PMID: 12124349. 2. Mahmoudian M, Mojaverian N. Efffect of noscapine, the antitussive opioid alkaloid, on bradykinin-induced smooth muscle contraction in the isolated ileum of the guinea-pig. Acta Physiol Hung. 2001;88(3-4):231-7. doi: 10.1556/APhysiol.88.2001.3-4.5. PMID: 12162581.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R, Darwiche N. Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis. 2015 Dec;20(12):1531-62. doi: 10.1007/s10495-015-1169-2. Review. PubMed PMID: 26362468.

2: Rida PC, LiVecche D, Ogden A, Zhou J, Aneja R. The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications. Med Res Rev. 2015 Sep;35(5):1072-96. doi: 10.1002/med.21357. Review. PubMed PMID: 26179481; PubMed Central PMCID: PMC4778555.

3: Chen X, Dang TT, Facchini PJ. Noscapine comes of age. Phytochemistry. 2015 Mar;111:7-13. doi: 10.1016/j.phytochem.2014.09.008. Review. PubMed PMID: 25583437.

4: Lopus M, Naik PK. Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics. Pharmacol Rep. 2015 Feb;67(1):56-62. doi: 10.1016/j.pharep.2014.09.003. Review. PubMed PMID: 25560576.

5: King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review. Am J Public Health. 2014 Aug;104(8):e32-42. doi: 10.2105/AJPH.2014.301966. Review. PubMed PMID: 24922138; PubMed Central PMCID: PMC4103240.

6: Fang ZZ, Gonzalez FJ. LC-MS-based metabolomics: an update. Arch Toxicol. 2014 Aug;88(8):1491-502. doi: 10.1007/s00204-014-1234-6. Review. PubMed PMID: 24710571.

7: Beaudoin GA, Facchini PJ. Benzylisoquinoline alkaloid biosynthesis in opium poppy. Planta. 2014 Jul;240(1):19-32. doi: 10.1007/s00425-014-2056-8. Review. PubMed PMID: 24671624.

8: Alberti C. Taxane- and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma. Eur Rev Med Pharmacol Sci. 2013 Jun;17(12):1658-64. Review. PubMed PMID: 23832735.

9: Jain V, Jain B, Tiwari P, Saini J, Jain UK, Pandey RS, Kumar M, Katare OP, Chandra R, Madan J. Nanosolvated microtubule-modulating chemotherapeutics: a case-to-case study. Anticancer Drugs. 2013 Apr;24(4):327-36. doi: 10.1097/CAD.0b013e32835ec414. Review. PubMed PMID: 23411683.

10: Hagel JM, Facchini PJ. Benzylisoquinoline alkaloid metabolism: a century of discovery and a brave new world. Plant Cell Physiol. 2013 May;54(5):647-72. doi: 10.1093/pcp/pct020. Review. PubMed PMID: 23385146.

11: Singh H, Singh P, Kumari K, Chandra A, Dass SK, Chandra R. A review on noscapine, and its impact on heme metabolism. Curr Drug Metab. 2013 Mar;14(3):351-60. Review. PubMed PMID: 22935070.

12: Verlee L, Verheij TJ, Hopstaken RM, Prins JM, Salomé PL, Bindels PJ. [Summary of NHG practice guideline 'Acute cough']. Ned Tijdschr Geneeskd. 2012;156(0):A4188. Review. Dutch. PubMed PMID: 22917039.

13: Gajewski MM, Alisaraie L, Tuszynski JA. Peloruside, laulimalide, and noscapine interactions with beta-tubulin. Pharm Res. 2012 Nov;29(11):2985-93. doi: 10.1007/s11095-012-0809-2. Review. PubMed PMID: 22733149.

14: Chandra R, Madan J, Singh P, Chandra A, Kumar P, Tomar V, Dass SK. Implications of nanoscale based drug delivery systems in delivery and targeting tubulin binding agent, noscapine in cancer cells. Curr Drug Metab. 2012 Dec;13(10):1476-83. Review. PubMed PMID: 22571485.

15: Bughani U, Li S, Joshi HC. Recent patents reveal microtubules as persistent promising target for novel drug development for cancers. Recent Pat Antiinfect Drug Discov. 2009 Nov;4(3):164-82. Review. PubMed PMID: 19673697.

16: Småbrekke L, Melbye H. [Pharmacological treatment of acute cough]. Tidsskr Nor Laegeforen. 2009 May 14;129(10):998-9. doi: 10.4045/tidsskr.08.0438. Review. Norwegian. PubMed PMID: 19448753.

17: Mahmoudian M, Rahimi-Moghaddam P. The anti-cancer activity of noscapine: a review. Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):92-7. Review. PubMed PMID: 19149691.

18: Kingston DG. Tubulin-interactive natural products as anticancer agents. J Nat Prod. 2009 Mar 27;72(3):507-15. doi: 10.1021/np800568j. Review. Erratum in: J Nat Prod. 2011 May 27;74(5):1352. PubMed PMID: 19125622; PubMed Central PMCID: PMC2765517.

19: Ohlsson S, Holm L, Myrberg O, Sundström A, Yue QY. Noscapine may increase the effect of warfarin. Br J Clin Pharmacol. 2008 Feb;65(2):277-8. Review. PubMed PMID: 17875192; PubMed Central PMCID: PMC2291222.

20: Zhou J, Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents. 2005 Jan;5(1):65-71. Review. PubMed PMID: 15720262.